This synthetic form called semaglutide mimics GLP-1’s actions in the body. The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Even as millions of older adults clamor for ...
The only GLP-1 medication available in pill form, at the time of this writing, is semaglutide. Studies seem to indicate that the pill form of semaglutide is just as effective as the injectable ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative. The stock is reasonably valued given the growth opportunities in front ...
Liily's older GLP-1 drug, Trulicity, meanwhile, continues to see its revenue sink as patients move to its newer GLP-1 drugs. Revenue fell 25% in the quarter to $1.3 billion. However, Lilly saw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results